Is Ocumension Therapeutics stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Ocumension Therapeutics 10 years ago, but if you had invested on Friday 10th of July 2020 when the price was HKD37.00, you would have made a loss of HKD-32.16 per share or -86.92%
Yes, the average daily trading liquidity for Ocumension Therapeutics is HKD1.73 million. You should therefore be able to get in and out of your positions relatively fast.
Ocumension Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Ocumension Therapeutics to be medium [0.7 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.